Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001415889-25-007856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-12 | 2025-03-10+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $53.08 | -75.4K | 103.9K | -42% | -$4.00M |
| DM | 2025-03-12 | 2025-03-10+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $31.93 | +75.4K | 115.2K | +190% | +$2.41M |
| DM | 2025-03-12 | 2025-03-10+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $0.00 | -75.4K | 4,114 | -95% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | S | D | 45,392 | $53.15 | 103,901 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-03-10 | M | A | 11,398 | $33.02 | 115,299 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-10 | S | D | 11,398 | $53.12 | 103,901 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-03-11 | S | D | 1,719 | $53.01 | 103,901 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $37.30 to $38.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-03-10 | S | D | 3,487 | $52.24 | 111,663 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.73 to $52.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2025-03-10 | S | D | 7,762 | $53.05 | 103,901 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.74 to $53.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-03-11 | M | A | 5,662 | $33.02 | 109,563 | D | — | — | |
| 8 | Common | Common Stock | 2025-03-11 | S | D | 5,662 | $53.02 | 103,901 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-03-11 | M | A | 1,719 | $33.02 | 105,620 | D | — | — | |
| 10 | Common | Common Stock | 2025-03-10 | M | A | 45,392 | $33.02 | 149,293 | D | — | — | |
| 11 | Common | Common Stock | 2025-03-10 | M | A | 11,249 | $25.69 | 115,150 | D | — | — | |
| 12 | Derivative | Stock Option (Right to Buy) | 2025-03-11 | M | D | 1,719 | $0.00 | 2,395 | D | $33.02 · — to 2029-01-21 | 1,719 Common Stock | (F8) Currently exercisable. |
| 13 | Derivative | Stock Option (Right to Buy) | 2025-03-10 | M | D | 11,249 | $0.00 | 33,751 | D | $25.69 · — to 2034-02-14 | 11,249 Common Stock | (F9) This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-03-11 | M | D | 5,662 | $0.00 | 13,126 | D | $33.02 · — to 2029-01-21 | 5,662 Common Stock | (F8) Currently exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-03-10 | M | D | 45,392 | $0.00 | 18,788 | D | $33.02 · — to 2029-01-21 | 45,392 Common Stock | (F8) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-03-10 | M | D | 11,398 | $0.00 | 4,114 | D | $33.02 · — to 2029-01-21 | 11,398 Common Stock | (F8) Currently exercisable. |